Randomized controlled trial reveals reduced spasticity with extracorporeal shock wave therapy in cerebral palsy and stroke patients, highlighting its potential as an adjunctive therapy.
Background: Spasticity, a common issue in cerebral palsy and stroke patients, significantly impairs mobility and quality of life. Non-invasive treatments like Extracorporeal Shock Wave Therapy (ESWT) have been explored for spasticity reduction.Objective: To evaluate the effectiveness of ESWT in reducing spasticity in cerebral palsy (CP) and stroke patients using the Modified Ashworth Scale (MAS).Methods: A randomized controlled trial (RCT) was conducted on 28 spastic CP and stroke patients. Participants were divided into Group A (n = 14, ESWT combined with conventional physiotherapy) and Group B (n = 14, conventional physiotherapy only). ESWT was administered at 5 Hz frequency, 0.10 mJ/mm² energy flux density, and 1500 impulses per session for 30 minutes, 5 days a week, for 6 months. Spasticity was assessed using MAS pre- and post-intervention. Data were analyzed using IBM SPSS version 25.Results: The ESWT group showed a significant reduction in MAS scores from 3.21 ± 0.25 to 1.77 ± 0.37 (p < 0.001), compared to the control group (3.10 ± 0.44 to 2.36 ± 0.60; p < 0.001).Conclusion: ESWT significantly reduced spasticity in CP and stroke patients, demonstrating its potential as an adjunctive therapy.
No takes yet. Share an insight, caveat, or question.
Jalal et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: